Topics
October 2014 | Cover Stories
Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine
Pravin U. Dugel, MD
November/December 2013 | Cover Stories
Enabling Personalized Medicine in the Management of Uveal Melanoma
The value of a repository for tumor biopsy specimens after gene expression profiling.
Thomas M. Aaberg Jr, MD
August 24, 2026
Oculis Doses First Patient in Phase 3 PIONEER-1 Trial of Privosegtor for Optic Neuritis
August 19, 2026
Eyconis Initiates First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet AMD
August 17, 2026
Duravyu Misses Primary Endpoint in Phase 3 LUGANO Trial but Reduces Treatment Burden in Wet AMD
August 14, 2026
Large UK Study Examines Impact of Anti-VEGF Treatment for DME on Progression to Proliferative Diabetic Retinopathy
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
MEDIA PLACEMENT SPONSORED BY CARL ZEISS MEDITEC AG
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
